GeneTrait Anti-ADHD Panel

GeneTrait’s Anti-ADHD panel evaluates genetic markers responsible for metabolism of many common medications related to attention-deficit/hyperactivity disorder, plus elevated risk of hyperhomocysteinemia.

NUMBER OF INDIVIDUAL GENES TESTED:

  • 6

MEDICATION CATEGORIES:

  • Anti-ADHD

RISK FACTORS EVALUATED:

  • Hyperhomocysteinemia